Makoto Asada Selected Research

Makoto Asada Research Topics

Disease

10	Neoplasms (Cancer) 08/2014 - 11/2002
3	Breast Neoplasms (Breast Cancer) 09/2008 - 11/2002
2	Invasive Fungal Infections 10/2011 - 10/2011
2	Neoplasm Metastasis (Metastasis) 09/2008 - 11/2002
1	Chagas Disease (American Trypanosomiasis) 01/2021
1	Tuberculosis (Tuberculoses) 01/2016
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2016
1	Malaria 01/2016
1	Neglected Diseases 01/2016
1	Lung Neoplasms (Lung Cancer) 08/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2014
1	Candidiasis (Moniliasis) 10/2011
1	Aspergillosis 10/2011
1	Infections 10/2011
1	Pulmonary Aspergillosis 10/2011
1	Fusariosis 10/2011
1	Lymphatic Metastasis 09/2008
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2008
1	Hypoxia (Hypoxemia) 03/2004

Drug/Important Bio-Agent (IBA)

5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 03/2004
3	Pharmaceutical PreparationsIBA 01/2021 - 05/2012
3	lenvatinibIBA 01/2014 - 02/2008
2	N- (3- cyano- 4- methyl- 1H- indol- 7- yl)- 3- cyanobenzene- sulfonamideIBA 08/2014 - 02/2004
2	Tyrosine Kinase InhibitorsIBA 08/2014 - 01/2010
2	Biomarkers (Surrogate Marker)IBA 01/2014 - 02/2004
2	Angiogenesis InhibitorsIBA 01/2014 - 02/2004
2	APX001AIBA 10/2011 - 10/2011
2	Phosphotransferases (Kinase)IBA 09/2008 - 02/2008
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 09/2008 - 02/2008
2	Integrin alpha6IBA 02/2003 - 11/2002
1	ProdrugsIBA 01/2021
1	ER 30346 (ravuconazole)IBA 01/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2014
1	ErbB Receptors (EGF Receptor)IBA 08/2014
1	N- (3- chloro- 7- indolyl)- 1,4- benzenedisulphonamide (E7070)IBA 05/2012
1	Irinotecan (Camptosar)FDA LinkGeneric 05/2012
1	SulfonamidesIBA 05/2012
1	Voriconazole (Vfend)FDA LinkGeneric 10/2011
1	Antifungal AgentsIBA 10/2011
1	Caspofungin (Cancidas)FDA Link 10/2011
1	Fluconazole (Zonal)FDA LinkGeneric 10/2011
1	liposomal amphotericin B FDA Link 10/2011
1	AzolesIBA 10/2011
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2010
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2010
1	Vascular Endothelial Growth Factor CIBA 09/2008
1	Bevacizumab (Avastin)FDA Link 09/2008
1	Imatinib Mesylate (Gleevec)FDA Link 02/2008
1	Stem Cell FactorIBA 02/2008
1	MacrolidesIBA 03/2004
1	pladienolide BIBA 03/2004
1	Integrin alpha2IBA 02/2004
1	matrigelIBA 02/2004
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 02/2004
1	Proteasome Endopeptidase Complex (Proteasome)IBA 02/2003
1	Integrin alpha6beta1IBA 02/2003
1	IntegrinsIBA 11/2002
1	Growth Factor ReceptorsIBA 11/2002

Therapy/Procedure

2	Oral Administration 02/2008 - 02/2004
1	Therapeutics 01/2014